Citi Pharma Limited (PSX:CPHL)
Pakistan
· Delayed Price · Currency is PKR 79.03
-0.35 (-0.44%)
At close: Apr 28, 2026
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 18.06 billion as of April 28, 2026. Its market cap has decreased by -21.29% in one year.
Market Cap
18.06B
Enterprise Value
20.61B
Revenue
14.10B
Ranking
n/a
PE Ratio
17.37
Stock Price
79.03
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 18.06B, an increase of 152.71%. That is a compound annual growth rate of 21.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 18.06B | -6.58% |
| Dec 31, 2025 | 19.33B | 24.21% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ferozsons Laboratories | 17.84B |
| Macter International | 13.49B |
| Highnoon Laboratories | 50.63B |
| AGP Limited | 52.32B |
| The Searle Company | 55.22B |
| Abbott Laboratories (Pakistan) | 90.09B |
| Otsuka Pakistan | 3.66B |
| GlaxoSmithKline Pakistan | 116.15B |